Ruiz-Limón et al. reported that after 6 months of treatment with TCZ, a recombinant humanized anti-human IL-6 receptor monoclonal antibody, NETosis generation was reduced in RA patients and that treatment of RA neutrophils with IL-6 induced an increase in NET formation [36]. The gene discussed is IL6; the disease is rheumatoid arthritis.